Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SANOB: Nitric Oxide and Bronchodilation in COPD
NCT01853787Phase 4Completed
- Sponsor
- University of Milan
- Start
- Jul 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of formoterol, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by University of Milan. Started Jul 2014; status: completed.
02
Drugs
formoterolsalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01853787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853787.